TY - JOUR
T1 - Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation
AU - on behalf of the HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation
AU - Yokoyama, Hisayuki
AU - Kanda, Junya
AU - Kato, Shunichi
AU - Kondo, Eisei
AU - Maeda, Yoshinobu
AU - Saji, Hiroo
AU - Takahashi, Satoshi
AU - Onizuka, Makoto
AU - Onishi, Yasushi
AU - Ozawa, Yukiyasu
AU - Kanamori, Heiwa
AU - Ishikawa, Jun
AU - Ohno, Yuju
AU - Ichinohe, Tatsuo
AU - Takanashi, Minoko
AU - Kato, Koji
AU - Atsuta, Yoshiko
AU - Kanda, Yoshinobu
N1 - Publisher Copyright:
© 2018, Springer Nature Limited.
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Although human leukocyte antigen (HLA) mismatch is often thought to be associated with a high incidence of cytomegalovirus (CMV) reactivation, it is not clear whether this process is mediated by HLA mismatch or other factors, such as acute graft-versus-host disease (aGVHD). Here we focused on cord blood transplantation (CBT) and examined the effects of HLA mismatch on the incidence of CMV reactivation while minimizing the effects of aGVHD. In a multivariate analysis considering aGVHD as a time-dependent covariate, a significant effect on the incidence of CMV reactivation was noted for HLA disparity (hazard ratio [HR]: 0.54 for 8/8 match compared with 3-allele mismatch) and development of aGVHD (HR: 1.26). Next, in an analysis excluding cases that developed aGVHD, the incidences of CMV reactivation for 8/8 match and 1-allele mismatch were low compared with those for other mismatches. These findings were supported by the multivariate analysis (HR: 0.49 for 8/8 match and 0.64 for 1-allele mismatch compared with 3-allele mismatch). Together, these results suggested that HLA mismatch was involved in CMV reactivation and was associated with high morbidity of opportunistic infection after CBT.
AB - Although human leukocyte antigen (HLA) mismatch is often thought to be associated with a high incidence of cytomegalovirus (CMV) reactivation, it is not clear whether this process is mediated by HLA mismatch or other factors, such as acute graft-versus-host disease (aGVHD). Here we focused on cord blood transplantation (CBT) and examined the effects of HLA mismatch on the incidence of CMV reactivation while minimizing the effects of aGVHD. In a multivariate analysis considering aGVHD as a time-dependent covariate, a significant effect on the incidence of CMV reactivation was noted for HLA disparity (hazard ratio [HR]: 0.54 for 8/8 match compared with 3-allele mismatch) and development of aGVHD (HR: 1.26). Next, in an analysis excluding cases that developed aGVHD, the incidences of CMV reactivation for 8/8 match and 1-allele mismatch were low compared with those for other mismatches. These findings were supported by the multivariate analysis (HR: 0.49 for 8/8 match and 0.64 for 1-allele mismatch compared with 3-allele mismatch). Together, these results suggested that HLA mismatch was involved in CMV reactivation and was associated with high morbidity of opportunistic infection after CBT.
UR - http://www.scopus.com/inward/record.url?scp=85056106831&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056106831&partnerID=8YFLogxK
U2 - 10.1038/s41409-018-0369-0
DO - 10.1038/s41409-018-0369-0
M3 - Article
C2 - 30401965
AN - SCOPUS:85056106831
SN - 0268-3369
VL - 54
SP - 1004
EP - 1012
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 7
ER -